- Home
- TIL vs WNEB Comparison
TIL vs WNEB Comparison
Compare TIL & WNEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- WNEB
- Stock Information
- Founded
- TIL 2018
- WNEB 1853
- Country
- TIL United States
- WNEB United States
- Employees
- TIL N/A
- WNEB N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- WNEB Savings Institutions
- Sector
- TIL Health Care
- WNEB Finance
- Exchange
- TIL Nasdaq
- WNEB Nasdaq
- Market Cap
- TIL 177.1M
- WNEB 195.7M
- IPO Year
- TIL 2021
- WNEB N/A
- Fundamental
- Price
- TIL $27.84
- WNEB $11.65
- Analyst Decision
- TIL Buy
- WNEB Buy
- Analyst Count
- TIL 6
- WNEB 2
- Target Price
- TIL $120.50
- WNEB $11.00
- AVG Volume (30 Days)
- TIL 159.0K
- WNEB 100.3K
- Earning Date
- TIL 08-13-2025
- WNEB 07-22-2025
- Dividend Yield
- TIL N/A
- WNEB 2.40%
- EPS Growth
- TIL N/A
- WNEB N/A
- EPS
- TIL N/A
- WNEB 0.59
- Revenue
- TIL N/A
- WNEB $76,036,000.00
- Revenue This Year
- TIL N/A
- WNEB N/A
- Revenue Next Year
- TIL N/A
- WNEB $7.36
- P/E Ratio
- TIL N/A
- WNEB $19.79
- Revenue Growth
- TIL N/A
- WNEB 2.15
- 52 Week Low
- TIL $9.90
- WNEB $7.55
- 52 Week High
- TIL $92.00
- WNEB $11.99
- Technical
- Relative Strength Index (RSI)
- TIL 52.43
- WNEB 65.66
- Support Level
- TIL $25.79
- WNEB $10.94
- Resistance Level
- TIL $29.67
- WNEB $11.99
- Average True Range (ATR)
- TIL 2.62
- WNEB 0.32
- MACD
- TIL 0.10
- WNEB 0.04
- Stochastic Oscillator
- TIL 70.92
- WNEB 80.46
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About WNEB Western New England Bancorp Inc.
Western New England Bancorp Inc through its bank subsidiary, provides a range of financial services to individuals and companies in western Massachusetts and northern Connecticut. These services include commercial lending, residential lending and consumer lending, checking, savings and time deposits, cash management, and wealth management. Substantially all of the company's revenues, profits, and assets are derived by the Bank from banking products and services.